Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

20Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt l and PTEN 2. Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental-cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.

Cite

CITATION STYLE

APA

David, O. (2001). Akt and PTEN: New diagnostic markers of non-small cell lung cancer? Journal of Cellular and Molecular Medicine, 5(4), 430–433. https://doi.org/10.1111/j.1582-4934.2001.tb00178.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free